Over-Represented KEGG Pathways TAED | |||||
---|---|---|---|---|---|
KEGG Pathway | Mapped Lineages Under Positive Selection | Lineages Under Positive Selection Mapped | Uncorrected P-value | FDR P-value | Bonferroni P-value |
Metabolic pathways | 7.63% | 5.73% | <  0.0001 | <  0.0001 | <  0.0001 |
Olfactory transduction | 12.25% | 2.67% | <  0.0001 | <  0.0001 | <  0.0001 |
Biosynthesis of secondary metabolites | 7.85% | 1.90% | <  0.0001 | <  0.0001 | <  0.0001 |
Biosynthesis of antibiotics | 7.96% | 1.11% | <  0.0001 | <  0.0001 | <  0.0001 |
Neuroactive ligand-receptor interaction | 6.45% | 1.05% | <  0.0001 | <  0.0001 | <  0.0001 |
Microbial metabolism in diverse environments | 7.86% | 0.85% | <  0.0001 | <  0.0001 | <  0.0001 |
Protein processing in endoplasmic reticulum | 6.97% | 0.72% | <  0.0001 | <  0.0001 | <  0.0001 |
Purine metabolism | 6.63% | 0.69% | <  0.0001 | <  0.0001 | <  0.0001 |
Herpes simplex infection | 6.18% | 0.68% | 0.0047 | 0.0128 | 1.0000 |
Carbon metabolism | 8.63% | 0.62% | <  0.0001 | <  0.0001 | <  0.0001 |
RNA transport | 6.45% | 0.59% | <  0.0001 | <  0.0001 | 0.0056 |
Influenza A | 6.74% | 0.59% | <  0.0001 | <  0.0001 | <  0.0001 |
Fluid shear stress and atherosclerosis | 6.21% | 0.54% | 0.0061 | 0.016 | 1.0000 |
Lysosome | 6.72% | 0.52% | <  0.0001 | <  0.0001 | <  0.0001 |
Glycerophospholipid metabolism | 7.61% | 0.49% | <  0.0001 | <  0.0001 | <  0.0001 |
Non-alcoholic fatty liver disease (NAFLD) | 6.19% | 0.47% | 0.0128 | 0.0325 | 1.0000 |
Pancreatic secretion | 8.86% | 0.43% | <  0.0001 | <  0.0001 | <  0.0001 |
Peroxisome | 7.37% | 0.42% | <  0.0001 | <  0.0001 | <  0.0001 |
Toxoplasmosis | 6.50% | 0.41% | 0.0001 | 0.0003 | 0.0341 |
Phosphatidylinositol signaling system | 6.70% | 0.41% | <  0.0001 | <  0.0001 | 0.0004 |
Glycerolipid metabolism | 10.21% | 0.39% | <  0.0001 | <  0.0001 | <  0.0001 |
Drug metabolism - cytochrome P450 | 12.03% | 0.39% | <  0.0001 | <  0.0001 | <  0.0001 |
Th17 cell differentiation | 6.38% | 0.38% | 0.0013 | 0.0039 | 0.4944 |
Valine_ leucine and isoleucine degradation | 11.00% | 0.38% | <  0.0001 | <  0.0001 | <  0.0001 |
Chemical carcinogenesis | 9.32% | 0.38% | <  0.001 | <  0.0001 | <  0.0001 |